Haleon PLC (HLN)
9.54
+0.06
(+0.63%)
USD |
NYSE |
Nov 21, 12:47
Haleon Price: 9.54 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 9.47 | 9.505 | 9.44 | 9.48 | 6.736M |
| Nov 19, 2024 | 9.42 | 9.50 | 9.40 | 9.48 | 5.684M |
| Nov 18, 2024 | 9.35 | 9.44 | 9.320 | 9.43 | 5.872M |
| Nov 15, 2024 | 9.36 | 9.41 | 9.34 | 9.39 | 8.494M |
| Nov 14, 2024 | 9.32 | 9.36 | 9.29 | 9.31 | 7.273M |
| Nov 13, 2024 | 9.19 | 9.25 | 9.10 | 9.23 | 9.325M |
| Nov 12, 2024 | 9.30 | 9.325 | 9.239 | 9.28 | 7.519M |
| Nov 11, 2024 | 9.55 | 9.59 | 9.49 | 9.51 | 8.505M |
| Nov 08, 2024 | 9.56 | 9.62 | 9.53 | 9.61 | 7.397M |
| Nov 07, 2024 | 9.51 | 9.62 | 9.51 | 9.60 | 7.514M |
| Nov 06, 2024 | 9.57 | 9.59 | 9.49 | 9.54 | 6.102M |
| Nov 05, 2024 | 9.71 | 9.79 | 9.700 | 9.77 | 6.052M |
| Nov 04, 2024 | 9.85 | 9.86 | 9.74 | 9.76 | 4.533M |
| Nov 01, 2024 | 9.80 | 9.818 | 9.71 | 9.73 | 4.814M |
| Oct 31, 2024 | 9.66 | 9.76 | 9.585 | 9.69 | 7.689M |
| Oct 30, 2024 | 9.77 | 9.86 | 9.75 | 9.80 | 6.371M |
| Oct 29, 2024 | 9.91 | 9.95 | 9.89 | 9.90 | 5.984M |
| Oct 28, 2024 | 9.97 | 10.00 | 9.93 | 9.98 | 5.228M |
| Oct 25, 2024 | 9.93 | 9.93 | 9.84 | 9.85 | 3.052M |
| Oct 24, 2024 | 9.94 | 9.95 | 9.865 | 9.89 | 4.175M |
| Oct 23, 2024 | 9.88 | 9.91 | 9.85 | 9.90 | 3.581M |
| Oct 22, 2024 | 9.88 | 9.93 | 9.860 | 9.91 | 3.572M |
| Oct 21, 2024 | 10.02 | 10.05 | 9.94 | 9.98 | 3.094M |
| Oct 18, 2024 | 10.06 | 10.09 | 10.02 | 10.09 | 1.982M |
| Oct 17, 2024 | 10.04 | 10.15 | 10.04 | 10.08 | 4.462M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.63
Minimum
Sep 02 2022
10.69
Maximum
Oct 01 2024
8.221
Average
8.26
Median
May 26 2023
Price Benchmarks
| Pfizer Inc | 25.17 |
| GSK PLC | 33.44 |
| Smith & Nephew PLC | 25.10 |
| Adaptimmune Therapeutics PLC | 0.6429 |
| Biodexa Pharmaceuticals PLC | 4.60 |
Price Related Metrics
| PE Ratio | 28.20 |
| PS Ratio | 3.076 |
| PEG Ratio | 16.82 |
| Price to Book Value | 2.054 |
| Earnings Yield | 3.55% |
| Market Cap | 43.13B |
| PEGY Ratio | 8.442 |
| Operating PE Ratio | 16.18 |
| Normalized PE Ratio | 28.30 |